Salo A L, Randall C L, Becker H C, Patrick K S
Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston 29425-0742, USA.
Neurotoxicol Teratol. 1995 Sep-Oct;17(5):577-81. doi: 10.1016/0892-0362(95)00018-m.
The teratogenic effects of cocaine and ethanol were investigated using an acute treatment model of C57BL/6J mice treated on gestation day 15 (GD15) with evaluation on GD17. Females were intubated once with a subteratogenic dose of ethanol (0 or 4 g/kg) and injected subcutaneously twice, 1 h apart, with equal doses of cocaine HCl (0 or 60 mg/kg), for a final daily dose of 120 mg/kg. The first cocaine injection followed ethanol by 10 min. Blood ethanol levels (BEL) and plasma cocaine levels were determined, and pair-feeding was employed. The results revealed no group differences on pregnancy outcome. That is, maternal weight gain, total number of implants, prenatal mortality, and fetal body weight were not statistically different. No significant differences in BEL or plasma cocaine levels were found among the various treatment groups. These results suggest that, under these conditions, relatively high levels of cocaine (120 mg/kg, SC), given alone or in combination with subteratogenic doses of ethanol late in pregnancy, are not teratogenic in mice.
利用一种急性治疗模型对可卡因和乙醇的致畸作用进行了研究,该模型采用在妊娠第15天(GD15)对C57BL/6J小鼠进行处理,并在GD17进行评估。雌性小鼠单次经口给予低于致畸剂量的乙醇(0或4 g/kg),并皮下注射两次,间隔1小时,给予等量的盐酸可卡因(0或60 mg/kg),最终每日剂量为120 mg/kg。第一次可卡因注射在乙醇给药后10分钟进行。测定了血液乙醇水平(BEL)和血浆可卡因水平,并采用配对喂养。结果显示各实验组在妊娠结局方面无组间差异。也就是说,母体体重增加、着床总数、产前死亡率和胎儿体重在统计学上无差异。各治疗组之间在BEL或血浆可卡因水平上未发现显著差异。这些结果表明,在这些条件下,相对高剂量的可卡因(120 mg/kg,皮下注射)单独使用或在妊娠后期与低于致畸剂量的乙醇联合使用时,对小鼠不具有致畸性。